Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Cancer Recurrent”

750 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 750 results

Not applicableLooking for participantsNCT06076811
What this trial is testing

DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies

Who this might be right for
Colorectal NeoplasmsColorectal CancerColorectal Adenocarcinoma+3 more
University of Aarhus 1,600
Testing effectiveness (Phase 2)Study completedNCT00004911
What this trial is testing

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00003544
What this trial is testing

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)Temporarily pausedNCT00609310
What this trial is testing

Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence

Who this might be right for
Colorectal Cancer
Technische Universität Dresden 382
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)UnknownNCT00303745
What this trial is testing

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914
What this trial is testing

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis
Tianjin Medical University Cancer Institute and Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00030563
What this trial is testing

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Washington
Large-scale testing (Phase 3)Study completedNCT03879109
What this trial is testing

Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer

Who this might be right for
Rectal Cancer
University Hospital, Bordeaux 58
Testing effectiveness (Phase 2)Ended earlyNCT01545141
What this trial is testing

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Roswell Park Cancer Institute 15
Not applicableStudy completedNCT00897754
What this trial is testing

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 200
Testing effectiveness (Phase 2)Ended earlyNCT00276861
What this trial is testing

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer

Who this might be right for
Colorectal Cancer
University of Miami 10
Large-scale testing (Phase 3)Study completedNCT00389870
What this trial is testing

Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

Who this might be right for
Colorectal Cancer
University of Leeds 1,198
Not applicableStudy completedNCT06440044
What this trial is testing

Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism

Who this might be right for
Thrombosis, VenousColo-rectal CancerBleeding
Sixth Affiliated Hospital, Sun Yat-sen University 2,000
Large-scale testing (Phase 3)UnknownNCT00021281
What this trial is testing

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Study completedNCT00002828
What this trial is testing

Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005864
What this trial is testing

Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Next Page